Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy

Am Heart J. 2004 May;147(5):790-1. doi: 10.1016/j.ahj.2004.02.002.

Authors

Peter J Cawley¹, Sana M Al-Khatib

Affiliation

¹ Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA. [email protected]

PMID: 15131532
DOI: 10.1016/j.ahj.2004.02.002

No abstract available

MeSH terms

Amiodarone / therapeutic use*
Anti-Arrhythmia Agents / therapeutic use*
Cardiomyopathy, Dilated / complications*
Defibrillators, Implantable*
Evidence-Based Medicine
Humans
Randomized Controlled Trials as Topic
Tachycardia, Ventricular / complications
Tachycardia, Ventricular / drug therapy
Tachycardia, Ventricular / therapy*
Treatment Outcome

Substances

Anti-Arrhythmia Agents
Amiodarone